Biocontrol Subsidiary IDT To
Selected Abstract
Biocontrol Subsidiary, IDT, To Conduct Cancer Study With The University of Texas Medical Branch at Galveston
PITTSBURGH, Sept. 11 /PRNewswire/ -- Biocontrol Technology, Inc. (Nasdaq: BICO) announced today that its subsidiary, IDT, Inc., in conjunction with HemoCleanse, Inc., has entered into an agreement with the University of Texas Medical Branch at Galveston (UTMB) to begin a human clinical trial in ... September 11, 1997; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Biocontrol Subsidiary, IDT, To Conduct Cancer Study With The University of Texas Medical Branch at Galveston
|
